Is the influential theory of "disruptive innovation" bunk? Or to put it in a less specific and blunt way: Are businesses — and business professors — too quick to accept as fact theories that aren't supported by rigorous data? Both propositions are true, says Smith School professor Brent Goldfarb, who made that provocative case in a major presentation at the Academy of Management conference last month in
The U.S. Food and Drug Administration is working to harness fast-accumulating personal health data from the likes of Twitter, Facebook and wearable devices. But more than 90 percent of analysts’ efforts to capitalize on that data falls below the targeted efficiency level for the FDA’s Office of Surveillance and Biometrics in its Center for Device and Radiological Health, said Isaac Chang, who directs post-market surveillance for that office. “We have observations of signals and patterns,” he said. “But they’re one-off maps.”
On Sept. 3, 2015, Smith freshmen were treated to another high-profile professional event called “Beyond Majors” as part of the ongoing SmithStart program. Throughout the evening, students traveled from one room to another listening to representatives and recruiters of different firms talk about what they do at the company, and how their industry feeds off of certain majors offered at Smith.
On Sept. 9, 2015, the undergraduate Class of 2016 gathered in the Van Munching Courtyard for the Third Annual “Feed the Terps” Senior BBQ, the first in a series of events designed to celebrate seniors at the University of Maryland’s Robert H. Smith School of Business.
The Smith School hosted a forum Tuesday on global market volatility, aimed at making sense of the recent tumult in international markets — notably in China, but also spilling over into other regions, including the United States. Finance faculty participants Russ Wermers, Haluk Unal, Albert "Pete" Kyle, Bill Longbrake, Phillip L. Swagel and Steve Heston. share their insights.